Biopharma firm Thousand Oaks raises $64m led by CICC fund, Goldstone

Thousand Oaks Biopharmaceuticals Co., Ltd has raised 450 million yuan ($64 million) in a Series B round of financing jointly led by CICC Capital’s sub-fund CICC Jiatai and CITIC Securities’ private equity arm Goldstone Investment Limited. 

China Construction Bank’s investment vehicle CCB International, Wens Investment and Shanghai Huaxu Investment also joined the round, the company said in the statement. 

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter